DeuteRx

$1.4M revenue • 8 employees • 300 Brickstone Square Suite 201, Andover, MA, 01810, United States

Last Updated Apr 24, 2025

Company Overview

Company Name

DeuteRx

Address

300 Brickstone Square Suite 201, Andover, MA, 01810, United States

Approx. Annual Revenue

$1.4M

Employees

8

Established

2012

About DeuteRx

DeuteRx is a virtual biopharmaceutical company based in Andover, MA, United States. Formed in 2012, the company focuses on improving racemic drugs through its Deuterium-Enabled Chiral Switching (DECS) technology, which isolates a single stereoisomer to reduce side effects and improve efficacy. DeuteRx has applied DECS to clinical therapies, including deuterium-stabilized versions of pioglitazone for nonalcoholic steatohepatitis and lenalidomide, which have been acquired by other pharmaceutical companies.

Business Profile

Read from the DeuteRx website on Oct 10, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
7/10 · Copyright notice says 2026; No contact form or booking; Thin content on homepage
Footer copyright year
2026

More Companies in Massachusetts

Browse all companies in Massachusetts →

Frequently Asked Questions about DeuteRx

Categories

Technologies Used

Key Decision Makers

Sheila Dewitt CEO
LinkedIn